Securities code: 002294 securities abbreviation: Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) No.: 2022-015
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Announcement on the progress of repurchasing shares of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without falsehood
False records, misleading statements or material omissions.
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (hereinafter referred to as “the company”) held the 17th meeting of the 5th board of directors and the 14th meeting of the 5th board of supervisors on July 25, 2021, and deliberated and adopted the proposal on repurchase of shares of the company. The company plans to use its own funds to repurchase shares in the form of centralized bidding transaction. The type of shares to be repurchased is RMB common shares (A shares) issued by the company. The total amount of funds to be repurchased shall not be less than RMB 100 million (inclusive) and not more than RMB 200 million (inclusive). The price of repurchased shares shall not exceed RMB 33 / share (inclusive). If the share repurchase plan is approved by the board of directors, the time limit shall not exceed 12 months from the date of implementation of the share repurchase plan. The specific number of shares to be repurchased shall be subject to the actual number of shares to be repurchased at the expiration of the repurchase period.
On September 5, 2021, the company held the 19th meeting of the 5th board of directors and the 16th meeting of the 5th board of supervisors, deliberated and adopted the proposal on increasing the amount of shares repurchased by the company, which changed the total amount of funds to be used for repurchase from “not less than RMB 100 million (inclusive) to not more than RMB 200 million (inclusive)”, Adjusted to “not less than 200 million yuan (inclusive) and not more than 400 million yuan (inclusive)”. On January 28, 2022, the company held the 25th meeting of the 5th board of directors and the 19th meeting of the 5th board of supervisors, deliberated and adopted the proposal on increasing the amount of shares repurchased by the company, Adjust the total amount of funds to be used for repurchase from “not less than 200 million yuan (inclusive) and not more than 400 million yuan (inclusive)” to “not less than 500 million yuan (inclusive) and not more than 70 million yuan (inclusive)”. (for details, please refer to the announcement on share repurchase scheme of the company and the repurchase report published in the information disclosure media China Securities Journal, securities times and www.cn.info.com.cn on July 26, 2021, July 29, 2021, September 7, 2021 and January 29, 2022 respectively Announcement on increasing the amount of shares repurchased by the company.)
1、 Progress of share repurchase
According to the company law, Shenzhen Stock Exchange Stock Listing Rules, Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 9 – share repurchase and other relevant laws, regulations and normative documents, during the repurchase period, the company shall disclose the repurchase progress as of the end of last month within the first three trading days of each month. The company’s repurchase progress by the end of last month is now announced as follows:
As of January 31, 2022, the company has repurchased 14863907 shares of the company through centralized bidding trading through the special securities repurchase account, accounting for 1.33% of the current total share capital of the company. The maximum transaction price is 30.19 yuan / share, the minimum transaction price is 23.91 yuan / share, and the total transaction amount is 397.526 million yuan (excluding transaction costs). This repurchase complies with the established share repurchase plan and the requirements of relevant laws and regulations.
2、 Other instructions
1. The time, quantity, method, price range and capital source of the company’s share repurchase are in line with the company’s repurchase report and the announcement on increasing the amount of shares repurchased by the company.
2. The price of shares repurchased by the company does not exceed the upper limit of 33 yuan / share (inclusive) specified in the share repurchase plan. The source of repurchase funds is the company’s own funds, which does not exceed the upper limit of total funds specified in the repurchase report and the announcement on increasing the amount of shares repurchased by the company.
3. The time for the company to repurchase shares, the number of shares to be repurchased and the entrustment period of centralized bidding transactions comply with the relevant provisions of Articles 17, 18 and 19 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 9 – repurchase of shares:
(1) The company has not repurchased its shares during the following periods:
a) If the announcement date is delayed due to special reasons within 10 trading days before the announcement of the company’s annual report and semi annual report, it shall be calculated from the 10 trading days before the original scheduled announcement date;
b) Within ten trading days before the announcement of the company’s quarterly report, performance forecast and performance express;
c) From the date of occurrence of major events that may have a significant impact on the trading price of the company’s shares or in the process of decision-making to the date of disclosure according to law;
d) Other circumstances prescribed by the CSRC.
(2) The cumulative trading volume of the company’s shares in the five trading days before the date of the company’s first share repurchase (July 28, 2021) was 19921447 shares. Since the date of the repurchase, the maximum number of shares repurchased by the company every five trading days is 4688767 shares (from July 29, 2021 to August 4, 2021). The number of shares repurchased by the company every five trading days does not exceed 25% of the cumulative trading volume of the company’s shares in the five trading days before the date of the first repurchase.
(3) The repurchase of shares by the company meets the following requirements:
a) The entrustment price shall not be the price limited by the trading increase of the company’s shares on the same day;
b) No entrustment of share repurchase shall be made within the opening call auction of Shenzhen Stock Exchange, half an hour before the closing and within the trading day when the stock price has no limit on rise or fall;
c) Other requirements stipulated by the CSRC and Shenzhen Stock Exchange.
4. The company will continue to implement the repurchase plan during the repurchase period according to the market conditions, and will timely perform the obligation of information disclosure in accordance with laws, regulations and relevant provisions during the repurchase period. Please pay attention to investment risks.
It is hereby announced
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) board of directors
February 7, 2002
